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Transfusion of blood and/or component is an integral part of management and life-saving measure in the medical field. Not only does donor blood save lives but it also has the potential to endanger life through the risk of transmitting transfusion-transmitted infections (TTIs) in the absence of proper donor screening. TTIs include human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), syphilis, malaria, and others.\[[@ref1]\] To ensure safe and adequate blood transfusion services, an integrated strategy has been implemented through India\'s National blood policy. The main components of this strategy include a collection of blood only from voluntary, nonremunerated blood donors, screening for all TTIs, and reduction of unnecessary transfusion.\[[@ref2]\]

To reduce the TTIs, the Government of India mandates screening of each and every unit of blood for hepatitis B surface antigen (HBsAg), anti-HIV, anti-HCV, malaria and syphilis as per Drugs and Cosmetic Act-1945. India has more than 1.2 billion population among which 2.4 million are HIV positive,\[[@ref3]\] more than 40 million are HBV carriers with point prevalence of 3.7%\[[@ref4]\] and 12.5 million are HCV-positive persons\[[@ref5]\] with a prevalence of 1%.\[[@ref4]\] The seroprevalence of HIV, HBV, and HCV in various studies is estimated as 0.07%--0.53%, 1.09%--3.51%, and 0.20%--0.74%, respectively.\[[@ref6][@ref7][@ref8][@ref9]\] However, this is not the exact prevalence of these infections, but it gives us a rough estimate of the disease burden in the general population and allows to prompt implementation of preventive measures and also the formulation of health strategies. The objectives of this study are: (1) to find out the seroprevalence of TTIs among healthy blood donors at a tertiary teaching hospital in central India (Malwa region) and to explore yearly differences in the prevalence of these infections, and (2) to compare other studies undertaken in different parts of India to assess the burden of these infections. We did not divide our donor population in the voluntary and replacement categories as it was known fact that replacement donors have more seroprevalence for TTIs, due to which National blood policy encourages voluntary nonremunerated donation.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

This cross-sectional study was conducted at the blood bank, Sri Aurobindo Medical College and PG Institute, Indore (Madhya Pradesh), India over a period of 5 years from 2011 to 2015. Ethical clearance was taken by the Institutional Ethical Committee. Retrospective data were collected from various registers maintained in the blood bank and for prospective data; all the donors were carefully screened and selected after proper history, clinical examination, and satisfactory answering of detailed donor questionnaires. All the samples collected during the study were screened for TTIs using the following ELISA tests:

For HIV: P24 antigen and antibodies to HIV 1 and HIV 2 detection by Merilisa fourth generation kit (Meril Diagnostics Pvt. Ltd., Vapi, Gujarat, India)For HBV: HBsAg detection by Merilisa (Meril Diagnostics Pvt. Ltd., Vapi, Gujarat, India)For HCV: Antibodies to HCV detection by the third generation Erba Lisa ELISA kit (Transasia Bio-Medicals Ltd., Ringanwada, Daman, India).

All the reactive samples were discarded for donation as per the guidelines. The data collected were entered into a Microsoft Office Excel 2007 sheet and percentage and proportions for each variable were calculated. Statistical analysis was done using, Chi-square test and Chi-square test for trend analysis to know prevalence trends by age and by year of donation. *P* \< 0.05 was set as the level of significance.
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A total of 58,998 blood bags were collected during the 5-year study from 2011 to 2015. Male blood donation predominates over female donation; the female contribution was only 0.3% \[[Table 1](#T1){ref-type="table"}\].
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Year and Gender Wise Distribution of Blood Donors
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Out of the total donors screened, 674 (1.14%) donors were reactive for HIV, HBV, or HCV during the study. All seropositive donors were male. The highest prevalence among donors was seen for HBV (0.98%) followed by HIV (0.09%) and HCV (0.07%) in decreasing order. Yearly seroprevalence and linear trend of these TTIs are represented in [Table 2](#T2){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}, respectively. There was no statistically significant trend for HIV or HBV from 2011 to 2015 (χ^2^ for linear trend 0.06 and 1.49, *P* value 0.80 and 0.22, respectively). Seroprevalence of HCV shows a statistically significant increasing trend (χ^2^ for linear trend was 4.91 and *P* = 0.027) over the 5 years. We found coinfections of TTIs in a total of five patients (0.008%) in the 5-year study period, with positivity for HIV and HCV or HIV and HBV of both 0.003% and for triple infection of 0.002% (*n* = 1).

###### 

Year-Wise Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections in Donors
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The age range in our study was 18--58 years. The highest prevalence of all infections summed together was found in the age group of 31--40 years \[[Table 3](#T3){ref-type="table"}\]. The overall cumulative seroprevalence was lowest in donors of age \<20 years (0.15%) and then increased up to 40 years of age, followed by a decline with increasing age. This age-wise trend of cumulative seroprevalence was statistically significant (χ^2^ for trend = 24.77, *P* ≤ 0.0001). In all age groups, HBV seropositivity was highest. In individual infections, HIV and HCV seropositivity across the age group did not show any significant trend (χ^2^ for linear trend = 0.38, *P* = 0.54 for HIV, χ^2^ for linear trend = 0.016, *P* = 0.9 for HCV) whereas seropositivity of HBV showed a statistically significant increasing trend with increasing age (χ^2^ for linear trend = 30.46, *P* ≤ 0.0001). Linear trends of seroprevalence with age are shown in [Figure 2](#F2){ref-type="fig"}.
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Age Distribution of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Reactive Blood Donors
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Transfusion of blood and/or blood products are life-saving at one end but may be a route of transmission of TTI\'s. To prevent TTIs as a delayed complication of blood transfusion, Government of India mandates the screening of each and every unit of blood as per drugs and cosmetic rules. Despite following all measures such as strict donor selection criteria, voluntary, nonremunerated donation, and more sensitive methods to detect TTIs, some transmission events are still possible because of the window period, false negative results, and other technical errors.\[[@ref10]\]

Our study showed the male dominance (99.7%) in donation similar to the other studies.\[[@ref6][@ref7][@ref10][@ref11][@ref12][@ref13][@ref14]\] Less female contribution was because of higher incidence of anemia and low weight in childbearing age group females. Another important reason is a lack of awareness and enthusiasm among family members of potential female blood donors. Other factors such as fear of procedure, lack of motivation, and privacy are also of concern which can be improved by increasing awareness among females and by providing privacy in camps. None of the female donors was seropositive for TTIs in our study, similar to the other studies in which female seropositive donors statistically significantly less in number as compared to male donors.\[[@ref6][@ref10][@ref14][@ref15][@ref16]\] This finding might be due to less number of female donors and difference in risk behavior of females.

In this study, 45% of the total donors belongs to the 18--30 years age group similar to the study of Fernandes *et al*.\[[@ref1]\] (68.5%), Karmarkar *et al*.\[[@ref17]\] (47.6%), and Sinha *et al*.\[[@ref13]\] (44.54%) probably because of the increased awareness and enthusiasm for blood donation and also because of less disease ailments among these young population. The present study found a statistically significant trend with age for cumulative seroprevalence and in line with the study by Karmarkar *et al*.\[[@ref17]\] Our study, in concordance with the other studies across India, showed the highest seroprevalence for hepatitis B. Comparison of seroprevalence of HIV, HBV, and HCV with other studies is shown in [Table 4](#T4){ref-type="table"}.
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Comparison of Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus with Other Studies
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The overall seroprevalence of HIV and HCV was almost the similar or showed a slight difference in studies from South India,\[[@ref1]\] Western India (Gujarat),\[[@ref14][@ref21][@ref22]\] and central India,\[[@ref7][@ref8][@ref9][@ref25]\] whereas studies from North India\[[@ref10][@ref18][@ref19]\] showed a much higher prevalence of HCV. This difference might be due to the difference in the study period, sensitivity of detecting methods, number of donors and different risk behavior in the donor population.

The overall seroprevalence of HIV is much lower in our study (0.09%) as compared with India\'s overall HIV prevalence in adults (0.27%) but exact same with the Madhya Pradesh\'s prevalence (0.09%) estimated in 2011 by NACO.\[[@ref26]\] In our study, maximum seroprevalence of HIV was observed in 31--50-year-old age group (0.11%) whereas, Kaur *et al*.,\[[@ref10]\] Mandal and Mondal,\[[@ref20]\] and Makroo *et al*.\[[@ref27]\] reported the highest prevalence in 26--35 years, 18--35 years, and 18--30-year-old age groups, respectively. In accordance with our results, most studies\[[@ref10][@ref20][@ref27]\] reported the lowest prevalence on 45--50-year-old age groups. One study from Kolkata\[[@ref12]\] found a maximum HIV prevalence on \>50 year olds.

HIV seroprevalence across the age group was not statistically significant, whereas Das *et al*.\[[@ref12]\] reported statistically significant increasing trend. In this study, we observed no significant trend for changing HIV prevalence in the last 5 years in contrast to the national trend for decreasing HIV prevalence from 0.41% to 0.27% during 2001--2011\[[@ref28]\] and also found in other studies.\[[@ref7][@ref9][@ref15][@ref19][@ref20][@ref23][@ref24]\] One study by Sabharwal *et al*.\[[@ref29]\] from Rajasthan and one by Patel *et al*.\[[@ref21]\] from Gujarat showed an increasing trend of HIV from 2007 to 2011 and 2009 to 2011, respectively. These discordances may be due to the difference in the study period and donor population.

The overall seroprevalence of HBV in our study was lower as compared to other studies from central India,\[[@ref7][@ref8][@ref9][@ref25]\] whereas almost similar with studies from Western India.\[[@ref6][@ref14][@ref21][@ref22]\] In our study, HBV was more prevalent in the 31--40-year-old age group and lowest on the \<20-year-old age group, whereas Giri *et al*.,\[[@ref6]\] Kaur *et al*.,\[[@ref10]\] and Mandal and Mondal\[[@ref20]\] found the highest prevalence in \<35 year olds and the lowest in \>45 year olds. In line with Mandal and Mondal,\[[@ref20]\] we observed statistically significant trend of HBV seropositivity with age, whereas Das *et al*.\[[@ref12]\] and Giri *et al*.\[[@ref6]\] did not find any insignificant trend.

In the present study, no significant trend for changing HBV seropositivity was observed during the study period whereas Sharma *et al*.,\[[@ref7]\] Sawke *et al*.,\[[@ref9]\] Naskar *et al*.,\[[@ref16]\] Patel *et al*.,\[[@ref21]\] and Sabharwal *et al*.\[[@ref29]\] found increasing trend and Makroo *et al*.,\[[@ref2]\] Mandal and Mondal,\[[@ref20]\] Deshpande *et al*.\[[@ref23]\] and Koshy *et al*.\[[@ref19]\] found statistically significant declining trend. These conflicting results may be also due to the difference in the study period and the donor population.

Overall HCV seroprevalence in the present study was much lower from the studies of North India.\[[@ref10][@ref18][@ref19]\] because of increased risk behavior (intravenous drug users) of their population. Mandal and Mondal\[[@ref20]\] and Makroo *et al*.\[[@ref30]\] observed statistically significant declining trend of HCV seropositivity with advancing age, whereas Das *et al*.\[[@ref12]\] found no significant trend across the age groups similar to the present study. Naskar *et al*.\[[@ref16]\] and Sabharwal *et al*.\[[@ref29]\] found statistically significant increasing trend of HCV seropositivity during their study period similar to our study, whereas one large study from North India\[[@ref30]\] did not find any significant change. Overall, the conflicting results may be due to differences in the donor base, study period, testing methodology, the degree to which the risk factors are prevalent in the donor population, literacy rate, and self-exclusion of high-risk donors by awareness programs.
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The overall prevalence for TTIs in our study from donors of Malwa region was lower as compared to other parts of India. The seroprevalence of HCV showed an increasing trend from 2011 to 2015, whereas we did not observe any statistically significant trend in the HIV and HBV. The increasing trend of HCV infection indicates the need for more awareness programs and education in the general population for the risk factors and complications because evolution to chronic stage then cirrhosis and eventually hepatocellular carcinoma.

Finally, exclusively voluntary, nonremunerated healthy donors blood donation, strict following of screening criteria, usage of more sensitive detection methods, self-exclusion of high-risk donors, avoidance of unnecessary blood transfusion and optimal usage of blood units are the key factors for safe blood transfusion and efficient transfusion services in our area.
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